LONDON (Reuters) - Britain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer, leaving it uncertain if the U.S. drugmaker would pull off a plan to create the world's biggest pharmaceuticals group.
(Reporting by Ben Hirschler, Editing by Paul Sandle)